Table 2.
Pre-COVID-19 period (1st February 2020 to 15th March 2020) | COVID-19 period (16th March 2020 to 30th April 2020) | Decrease % | ||
---|---|---|---|---|
PM total | 343 | 156 | ↓54.5% | <0.001 |
PM single-chamber | 138 (40.2%) | 70 (44.9%) | ↓ 49.3% | |
PM dual-chamber | 182 (53.1%) | 80 (51.3%) | ↓56.0% | |
PM CRT | 23 (6.7%) | 6 (3.8%) | ↓73.9% | |
ICD total | 91 | 33 | ↓63.7% | <0.001 |
ICD single-chamber | 52 (57.1%) | 14 (42.4%) | ↓73.1% | |
ICD dual-chamber | 7 (7.7%) | 1 (3.0%) | ↓85.7% | |
ICD CRT | 26 (28.6%) | 17 (51.5%) | ↓34.6% | |
ICD S-ICD | 6 (6.6%) | 1 (3.0%) | ↓83.3% | |
Primary prevention | 48 (52.7%) | 16 (48.5%) | ↓66.7% | |
ICD single-chamber | 25 | 4 | ||
ICD dual-chamber | 3 | 0 | ||
ICD CRT | 16 | 12 | ||
S-ICD | 4 | 0 | ||
Secondary prevention | 43 (47.3%) | 17 (51.5%) | ↓60.5% | |
ICD single-chamber | 27 | 10 | ||
ICD dual-chamber | 4 | 1 | ||
ICD CRT | 10 | 5 | ||
S-ICD | 2 | 1 | ||
Overall | 434 | 189 | ↓56.5% | <0.001 |
CRT, cardiac resynchronization therapy; ICD, implantable cardiac defibrillator; S-ICD, subcutaneous implantable cardiac defibrillator; PM, pacemaker.